Shanghai Haohai Biological Technology Co., Ltd. (HKG:6826)
Hong Kong · Delayed Price · Currency is HKD 15.85
-0.17 (-1.06%)
Nov 10, 2026, 4:08 PM HKT
HKG:6826 Market Cap
HKG:6826 has a market cap or net worth of 7.14 billion as of November 9, 2026. It is the 10,601st most valuable company in the world and the 516th biggest in Hong Kong. Its market cap has decreased by 37.91% in one year.
Market Cap
7.14B
Enterprise Value
5.11B
Revenue
2.64B
Global Rank
Country Rank
#516 Hong Kong
PE Ratio
28.45
ChartMarket Cap Chart
Since April 30, 2015, HKG:6826's market cap has decreased from 9.34B to 7.14B, a decrease of -23.63%. That is a compound annual growth rate of -2.31%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 10, 2026 | 7.14B | -29.82% |
| Dec 31, 2025 | 10.17B | -23.81% |
| Dec 31, 2024 | 13.35B | -24.15% |
| Dec 29, 2023 | 17.60B | 7.10% |
| Dec 30, 2022 | 16.43B | -29.33% |
| Dec 31, 2021 | 23.25B | 40.30% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Everest Medicines | 9.50B |
| Duality Biotherapeutics | 9.50B |
| HBM Holdings | 8.57B |
| CStone Pharmaceuticals | 8.51B |
| GenFleet Therapeutics (Shanghai) | 8.07B |
| Suzhou Ribo Life Science | 7.33B |
| Nanjing Leads Biolabs | 7.13B |
| Shaanxi Micot Pharmaceutical Technology | 6.24B |